Factor X Level Test in Lahore at Lahore PCR Lab

Factor X Level at Lahore PCR Lab

The Factor X Level test, also known as the Stuart-Prower factor assay, is a highly specialized hematological investigation that measures the activity or concentration of Factor X in the blood. Factor X is an essential glycoprotein synthesized in the liver and plays a pivotal role in the coagulation cascade, serving as the first enzyme in the common pathway of blood clotting. At Lahore PCR Lab, located in the heart of Lahore, Pakistan, we offer state-of-the-art coagulation testing to assist clinicians in diagnosing complex bleeding disorders, monitoring anticoagulant therapy, and evaluating liver synthetic function. Understanding how Factor X operates within the body is crucial for recognizing the clinical significance of this test. The coagulation cascade is a highly regulated sequence of physical and chemical events that leads to the formation of a stable fibrin clot, preventing excessive blood loss following vascular injury. This cascade is traditionally divided into the intrinsic, extrinsic, and common pathways. Factor X sits precisely at the intersection of the intrinsic and extrinsic pathways. It is activated to Factor Xa by either the tenase complex of the intrinsic pathway (comprising activated Factor IX, Factor VIII, calcium, and phospholipids) or the tissue factor-Factor VIIa complex of the extrinsic pathway. Once activated, Factor Xa associates with its cofactor, activated Factor V, along with calcium ions and a phospholipid surface, to form the prothrombinase complex. This highly efficient enzymatic complex catalyzes the conversion of prothrombin (Factor II) into thrombin (Factor IIa), which subsequently cleaves fibrinogen into fibrin, the structural backbone of a blood clot. Because Factor X occupies this central bottleneck in the coagulation process, any deficiency or dysfunction in this protein significantly impairs the body’s ability to form clots, leading to a high risk of hemorrhage. Conversely, monitoring its activity is vital when patients are treated with medications designed to inhibit clotting, such as direct oral anticoagulants or vitamin K antagonists. Lahore PCR Lab utilizes advanced automated coagulation analyzers and chromogenic assays to deliver precise, rapid, and clinically actionable Factor X measurements, ensuring the highest standards of patient care and diagnostic accuracy.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure the accuracy of the Factor X Level test, as various physiological factors and medications can significantly influence the results. Patients undergoing this test at Lahore PCR Lab should adhere to the following guidelines:

• Medication Disclosure: It is absolutely critical to inform your prescribing physician and the laboratory staff of all medications you are currently taking. This includes prescription blood thinners such as warfarin, heparin, low-molecular-weight heparin (LMWH), rivaroxaban, apixaban, and edoxaban, as well as over-the-counter anti-inflammatory drugs and herbal supplements.
• Anticoagulant Management: Depending on the clinical indication, your physician may instruct you to temporarily discontinue specific anticoagulant medications prior to the blood draw. Never stop taking any prescribed medication without direct instructions from your healthcare provider.
• Fasting Requirements: Routine fasting is generally not required for a standalone Factor X Level test. However, if other metabolic or lipid tests are scheduled for the same visit, a fasting period of 8 to 12 hours may be necessary.
• Hydration: Drinking plenty of water before the procedure is highly recommended. Proper hydration ensures that veins are well-filled and easily accessible, facilitating a smoother and quicker venipuncture process.
• Avoid Strenuous Activity: Patients should avoid intense physical exercise immediately before the blood draw, as extreme physical exertion can transiently alter coagulation factor levels and affect test outcomes.
• Stress Reduction: Arrive at the laboratory a few minutes early to rest and remain calm, as acute physiological stress can sometimes influence hemostatic parameters.

During the Procedure

The collection of a blood sample for a Factor X Level test is a routine, safe, and highly standardized procedure performed by the skilled phlebotomists at Lahore PCR Lab. The entire process takes only a few minutes and involves the following clinical steps:

• Patient Identification and Positioning: The phlebotomist will verify your identity using at least two unique identifiers. You will be comfortably seated or asked to lie down, and your arm will be positioned to expose the antecubital fossa (the bend of the elbow).
• Vein Selection and Site Preparation: The phlebotomist will apply a latex-free tourniquet a few inches above the selected site to increase venous pressure and make the veins more visible and palpable. The skin over the selected vein will be thoroughly cleansed with an antiseptic solution, typically 70% isopropyl alcohol, and allowed to air dry to prevent hemolysis and minimize the risk of infection.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection system will be gently inserted into the vein. You may feel a brief, mild pinching or stinging sensation as the needle enters the skin.
• Sample Collection: Blood is drawn directly into a light blue-top tube containing a precise concentration of buffered sodium citrate (3.2% or 0.109 M). The sodium citrate acts as a reversible anticoagulant by chelating calcium ions in the blood, preserving the coagulation factors for analysis. The tube must be filled completely to the designated fill line to maintain the critical 9:1 ratio of blood to anticoagulant; underfilling or overfilling can lead to inaccurate and invalid test results.
• Post-Draw Care: Once the tube is filled, the tourniquet is released, the needle is smoothly withdrawn, and immediate, gentle pressure is applied to the puncture site with a sterile gauze pad to promote hemostasis and prevent hematoma formation. A small adhesive bandage will be applied over the site.
• Sample Processing: The phlebotomist will gently invert the collection tube 3 to 4 times to ensure thorough mixing of the blood with the sodium citrate. The sample is then promptly transported to our clinical pathology department, where it undergoes double centrifugation to obtain platelet-poor plasma, which is essential for accurate coagulation factor assays.

When is a Factor X Level Performed?

Evaluation of Unexplained Bleeding Episodes

Physicians frequently request a Factor X Level test when a patient presents with unexplained, recurrent, or severe bleeding symptoms. These symptoms may include frequent and prolonged nosebleeds (epistaxis), easy bruising without significant trauma (ecchymosis), unusually heavy or prolonged menstrual bleeding (menorrhagia), blood in the urine (hematuria) or stool, and bleeding into joints (hemarthrosis) or muscles. By measuring the functional activity of Factor X, hematologists can determine if a deficiency in this specific clotting factor is the underlying cause of the bleeding diathesis, allowing for targeted therapeutic intervention.

Investigation of Abnormal Coagulation Screen Results

When routine coagulation screening tests, such as Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT), both show prolonged clotting times, it indicates a potential defect in the common pathway of the coagulation cascade. Because Factor X is a cornerstone of the common pathway, a prolonged PT and aPTT strongly warrant a quantitative Factor X assay. This test helps differentiate between deficiencies in the common pathway factors (Factors X, V, II, and fibrinogen) and identifies whether the prolongation is due to a specific factor deficiency or the presence of an inhibitory antibody.

Diagnosis of Congenital Factor X Deficiency

Congenital Factor X deficiency, historically known as Stuart-Prower factor deficiency, is an extremely rare autosomal recessive bleeding disorder affecting approximately one in one million individuals. The severity of clinical symptoms correlates closely with the level of functional Factor X activity in the plasma. Patients with severe congenital deficiency may experience life-threatening bleeding episodes, including intracranial hemorrhages, gastrointestinal bleeding, and severe hemarthrosis from early childhood. Performing a quantitative Factor X Level test is essential to confirm this genetic diagnosis, assess the severity of the disease, and guide prophylactic or on-demand replacement therapy.

Assessment of Acquired Factor X Deficiency

Acquired Factor X deficiency is more common than the congenital form and can arise from several clinical conditions. A classic and highly specific cause is systemic amyloidosis (particularly AL amyloidosis), where circulating Factor X is rapidly adsorbed onto amyloid fibrils deposited in tissues, leading to a profound clearance of the factor from the bloodstream. Other common causes of acquired deficiency include severe liver disease (which impairs the synthesis of all vitamin K-dependent clotting factors), severe vitamin K deficiency (essential for the functional activation of Factor X), and malabsorption syndromes. Measuring Factor X levels helps clinicians evaluate the severity of these underlying conditions and monitor the efficacy of treatment.

Monitoring Specific Anticoagulant Therapies

The Factor X Level test, particularly when performed as a chromogenic anti-Xa assay, is highly valuable for monitoring patients receiving specific anticoagulant therapies. While routine monitoring is not always required for direct oral anticoagulants (DOACs) like rivaroxaban and apixaban, or for low-molecular-weight heparin (LMWH), measuring anti-Xa activity becomes clinically necessary in special patient populations. These include patients with severe renal impairment, extreme body weight, pregnant women, pediatric patients, or individuals experiencing recurrent thrombotic events or unexplained bleeding while on therapy. The assay provides a precise measurement of drug activity, ensuring therapeutic efficacy while minimizing bleeding risks.

What Does a Factor X Level Detect?

The quantitative and qualitative evaluation of Factor X levels at Lahore PCR Lab is instrumental in detecting, diagnosing, and managing a wide range of clinical conditions and physiological states. This highly specialized assay is capable of detecting:

• Congenital Stuart-Prower Factor Deficiency: Confirms the presence of inherited mutations leading to reduced production or dysfunction of Factor X.
• Amyloidosis-Associated Coagulopathy: Identifies acquired Factor X deficiency caused by the adsorption of the factor onto systemic amyloid fibrils.
• Severe Hepatic Dysfunction: Detects impaired synthetic capacity of the liver, as Factor X is synthesized exclusively by hepatocytes.
• Vitamin K Deficiency: Evaluates the impact of inadequate vitamin K levels, which are necessary for the gamma-carboxylation of Factor X.
• Warfarin Therapeutic and Toxic Effects: Measures the suppression of functional Factor X levels caused by vitamin K antagonist therapy.
• Direct Factor Xa Inhibitor Activity: Quantifies the anticoagulant effect of medications like rivaroxaban, apixaban, and edoxaban.
• Low-Molecular-Weight Heparin (LMWH) Levels: Monitors the therapeutic concentration of LMWH via chromogenic anti-Xa activity.
• Unfractionated Heparin (UFH) Therapeutic Range: Assesses heparin activity, particularly in patients with heparin resistance or baseline prolonged aPTT.
• Disseminated Intravascular Coagulation (DIC): Detects the consumption of Factor X during widespread, uncontrolled systemic coagulation.
• Specific Factor X Inhibitors: Identifies the presence of rare neutralizing autoantibodies directed against Factor X.
• Lupus Anticoagulant Interference: Evaluates coagulation abnormalities in patients with antiphospholipid syndrome.
• Malabsorption-Induced Coagulation Defects: Detects clotting factor deficiencies secondary to celiac disease, Crohn’s disease, or pancreatic insufficiency.
• Biliary Obstruction Effects: Identifies impaired absorption of fat-soluble vitamin K due to obstructive jaundice, leading to low functional Factor X.
• Dilutional Coagulopathy: Assesses the depletion of clotting factors following massive blood transfusions or fluid resuscitation.
• Neonatal Hemorrhagic Disease: Evaluates low levels of vitamin K-dependent factors in newborns presenting with bleeding.
• Preoperative Bleeding Risk: Screens patients with borderline coagulation profiles before major surgical procedures to prevent intraoperative hemorrhage.
• Response to Vitamin K Therapy: Monitors the recovery of functional coagulation factor levels following vitamin K supplementation.
• Efficacy of Prothrombin Complex Concentrates (PCC): Evaluates the restoration of Factor X levels after the administration of emergency reversal agents.
• Impact of Broad-Spectrum Antibiotics: Detects secondary vitamin K deficiency caused by the eradication of vitamin K-producing gut microbiota.
• Physiological Variations in Pregnancy: Monitors the natural, hypercoagulable increase in Factor X levels during late pregnancy.
• Congenital Combined Factor Deficiencies: Assists in identifying rare multi-factor deficiencies involving other vitamin K-dependent proteins.
• Efficacy of Fresh Frozen Plasma (FFP) Transfusion: Assesses the post-transfusion increment of Factor X in bleeding patients.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely and accurate diagnostic results are critical for effective clinical decision-making and patient peace of mind. Our clinical pathology department is equipped with fully automated, high-throughput coagulation analyzers that streamline the testing process while maintaining strict quality control. The standard turnaround time for a Factor X Level test is typically within 24 to 48 hours from the time of sample collection. To ensure maximum convenience, Lahore PCR Lab provides multiple secure methods for accessing your diagnostic reports. Patients receive an automated SMS notification with a direct, secure link as soon as the report is verified by our consultant pathologist. Reports can also be viewed, downloaded, and printed directly from our official online patient portal. For patients requiring physical copies, reports are available for collection at our main facility and designated collection centers across Lahore, Pakistan. Our dedicated customer support team is always available to assist you with any inquiries regarding your results or report retrieval.

Factor X Level Findings Overview

The following table provides a comprehensive overview of the parameters evaluated during a Factor X Level test, along with typical normal ranges and potential clinical implications of abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Factor X Functional Activity	60% to 140% of normal pool plasma activity (0.60 to 1.40 U/mL)	Decreased: Congenital deficiency, liver disease, vitamin K deficiency, amyloidosis, warfarin therapy. Increased: Pregnancy, acute phase response.
Factor X Antigen Level	60% to 140% (measures total protein concentration)	Decreased: Type I deficiency (reduced synthesis). Normal with low activity: Type II deficiency (dysfunctional protein).
Prothrombin Time (PT) Correlation	11.0 to 13.5 seconds (may vary by reagent)	Prolonged: Indicates defect in extrinsic or common pathway, consistent with low Factor X activity.
Activated Partial Thromboplastin Time (aPTT)	25.0 to 35.0 seconds (may vary by reagent)	Prolonged: Indicates defect in intrinsic or common pathway, consistent with low Factor X activity.
Plasma Mixing Studies (1:1 Mix)	Correction of PT and aPTT to normal range	No Correction: Suggests presence of a circulating inhibitor (e.g., specific antibody or lupus anticoagulant) rather than simple factor deficiency.
Chromogenic Anti-Xa Assay	0.0 IU/mL (in the absence of heparin or direct oral anticoagulants)	Elevated: Reflects therapeutic or supratherapeutic levels of LMWH, unfractionated heparin, rivaroxaban, or apixaban.
Vitamin K Status Correlation	Normal functional levels of all vitamin K-dependent factors (II, VII, IX, X)	Concomitant decrease in Factors II, VII, IX, and X: Strongly indicative of nutritional vitamin K deficiency or oral anticoagulant therapy.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Factor X Level?

• Experienced healthcare professionals: Our laboratory is staffed by highly qualified hematopathologists, clinical technologists, and phlebotomists with extensive experience in coagulation diagnostics.
• Patient-focused care: We prioritize patient comfort, safety, and confidentiality, ensuring a seamless and stress-free diagnostic experience from registration to reporting.
• Quality diagnostic services: Lahore PCR Lab adheres to strict internal quality control protocols and participates in external quality assurance programs to guarantee the highest level of accuracy.
• Professional reporting: Our diagnostic reports are comprehensive, easy to read, and verified by expert consultant pathologists to provide clear clinical guidance.
• Modern diagnostic approach: We utilize state-of-the-art, fully automated coagulation analyzers and advanced chromogenic testing methodologies to deliver precise results.
• Comfortable environment: Our modern, clean, and hygienic collection centers across Lahore provide a welcoming and safe atmosphere for all patients.
• Convenient location: Strategically located in Lahore, Pakistan, our main laboratory and collection points are easily accessible, offering ample parking and convenient operating hours.
• Commitment to accurate diagnosis: We are dedicated to providing reliable, evidence-based diagnostic insights that empower physicians to deliver optimal patient care.